Page last updated: 2024-11-05

n-methylacrylamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-methylacrylamide: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID14471
CHEMBL ID3352942
MeSH IDM0473355

Synonyms (24)

Synonym
n-methyl-2-propenamide
ai3-61975
n-methylacrylamide
2-propenamide, n-methyl-
acrylamide, n-methyl-
brn 1737696
einecs 214-700-0
n-methylprop-2-enamide
6728c288m3 ,
1187-59-3
unii-6728c288m3
2-propenamide,n-methyl-
n-methyl acrylamide
DTXSID9041449
CHEMBL3352942
mfcd00053693
(s)-1-boc-3-amino-pyrrolidinehcl
n-methyl-acrylamide
Q27264058
SY057550
AB9590
A892932
EN300-244295
CS-0134564
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1170688GSH reactivity assessed as reaction half life through transition state modeling at pH 7.42014Journal of medicinal chemistry, Dec-11, Volume: 57, Issue:23
Chemical and computational methods for the characterization of covalent reactive groups for the prospective design of irreversible inhibitors.
AID1553480Half life of the compound2019Journal of medicinal chemistry, 06-27, Volume: 62, Issue:12
Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology.
AID1170692Reactivity of covalent reactive group using GSH reaction assessed as pseudo-first-order reaction at 37 degC by nuclear magnetic resonance spectroscopy2014Journal of medicinal chemistry, Dec-11, Volume: 57, Issue:23
Chemical and computational methods for the characterization of covalent reactive groups for the prospective design of irreversible inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's5 (71.43)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.52

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.52 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.59 (4.65)
Search Engine Demand Index39.48 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.52)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (14.29%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]